INVO | INVO Bioscience, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.6925 - 0.7435
52 Week Range	0.5000 - 3.50
Beta	3.00
Implied Volatility	529.98%
IV Rank	77.47%
Day's Volume	61,923
Average Volume	189,998
Shares Outstanding	3,906,070
Market Cap	2,714,719
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2020-11-02

Valuation
Profitability
Growth
Health
P/E Ratio	1.01
Forward P/E Ratio	N/A
EPS	0.69
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	25
Country	USA
Website	INVO

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

INVO's peers: ARAY, BBLG, BJDX, MODD, BMRA, CODX, BTCY, ICAD, ENTX, NLSP, ENVB, LIXT, CLPS, MOVE, MYO, NSPR, NSYS, NUWE, OPGN, OWLT, RPID, RSLS, SINT, SRTS, SSKN, TIVC, TLIS, TNON, HSCS, NXL

*Chart delayed

Analyzing fundamentals for INVO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see INVO Fundamentals page.

Watching at INVO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INVO Technicals page.